XML 26 R5.htm IDEA: XBRL DOCUMENT v3.23.4
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Operating activities      
Net loss for the year $ (7,372,225) $ (14,964,941) $ (8,650,763)
Non-cash items:      
Depreciation - right-of-use asset 72,450 6,037 0
Foreign exchange 45,348 (258,824) (223,787)
Shares recorded as consulting fees 0 27,250 0
Shares recorded as research and development 0 0 368,550
Share-based compensation 1,152,131 875,056 880,615
Interest on lease liability 19,750 2,173 0
Impairment of intangible assets 0 2,000 0
Changes in non-cash operating working capital items:      
Sales tax receivable 77,537 (4,372) (110,146)
Other receivables 41,261 (41,261)  
Prepaids 136,737 3,778 (89,920)
Accounts payable and accrued liabilities (1,197,254) 765,988 506,150
Net cash used in operating activities (7,024,265) (13,587,116) (7,319,301)
Financing activities      
Private placement proceeds 1,217,500 4,034,884 27,744,826
Finder's fees 0 (539,329) (1,516,317)
Share issue costs (26,976) (260,650) (290,309)
Pre-funded warrant proceeds 831,834 0 0
Special warrant proceeds 0 0 22,875
Refund of special warrant proceeds 0 0 (2,875)
Warrant exercise proceeds 253,440 1,653,170 97,400
Compensation warrant exercise proceeds 0 315,277 0
Principal portion of lease liability (86,112) (7,162) 0
Net cash from financing activities 2,189,686 5,196,190 26,055,600
Change in cash and cash equivalents (4,834,579) (8,390,926) 18,736,299
Effect of foreign exchange on cash (45,348) 258,824 223,787
Cash and cash equivalents, beginning of year 11,627,913 19,760,015 799,929
Cash and cash equivalents, end of year 6,747,986 11,627,913 19,760,015
SUPPLEMENTARY INFORMATION      
Debt settlement by issuing shares 0 0 18,500
Fair value ascribed by brokers' warrants issued 0 0 521,000
Fair value of RSUs exercised 232,500 0 0
Fair value of options issued as finders' fees $ 0 $ 39,355 $ 2,140